Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04332822 |
| Consolidated Lead Sponsor | Nordic Lymphoma Group |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 300 participants (ESTIMATED) |
| Registered Start Date | 2020-08-19 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Royal Prince Alfred Hospital | Camperdown, Australia | Open Hospital Dossier -> |
| Concord Repatriation General Hospital | Concord, Australia | Open Hospital Dossier -> |
| Royal Hobart Hospital | Hobart, Australia | Open Hospital Dossier -> |
| Fiona Stanley Hospital | Murdoch, Australia | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.